4000-520-616
欢迎来到免疫在线!(蚂蚁淘生物旗下平台)  请登录 |  免费注册 |  询价篮
主营:主营:防癌抗癌特殊化学品试剂
咨询热线电话
4000-520-616
当前位置: 首页 > 产品中心 > clinical_research > LKT/伊立替康/I6932/100毫克
商品详细LKT/伊立替康/I6932/100毫克
LKT/伊立替康/I6932/100毫克
LKT/伊立替康/I6932/100毫克
商品编号: I6932-100mg
品牌: lktlabs
市场价: ¥5980.00
美元价: 3588.00
产地: 美国(厂家直采)
公司:
产品分类: 临床研究
公司分类: clinical_research
联系Q Q: 3392242852
电话号码: 4000-520-616
电子邮箱: info@ebiomall.com
商品介绍
  • Description
  • ProductInfo
  • ShippingandStorage
  • Downloads
  • References

Description

Irinotecanisananalogofcamptothecinthatisusedclinicallytotreatcolonandovariancancers,amongothers.Irinotecanexhibitsanticancerchemotherapeutic,anti-angiogenic,andimmunosuppressiveactivities.IrinotecaninhibitsDNAtopoisomeraseIandsensitizestumorstotheeffectsofrADIation.Ingliomamodels,irinotecandecreasesthenumberoftumorvesselsanddecreasesexpressionofVEGFandHIF-1α,inhibitingtumorgrowth.Irinotecanalsomoderatesinhibitionofdendriticcelldifferentiationandmayproducecholinergicsideeffects,suggestingpotentialinhibitionofacetylcholinesterase(AChE)aswell.

ProductInfo

CasNo.

97682-44-5

Purity

≥98%

Formula

C33H38N4O6

FormulaWt.

586.68

ChemicalName

[1,4"-Bipiperidine]-1"-carboxylicacid(4S)-4,11-diethyl-3,4,12,14-tetrahydro-4-hydroxy-3,14-dioxo-1H-pyrano[3",4":6,7]indolizino[1,2-b]quinolin-9-ylester

Solubility

Insolubleinwater.SolubleinDMSO

Appearance

PaleYellowPowder

ShippingandStorage

StoreTemp

4°C

ShipTemp

Ambient

Downloads

MSDS

I6932MSDSPDF

InfoSheet

I6932InfoSheetPDF

References

HuJ,KinnJ,ZirakzadehAA,etal.Theeffectsofchemotherapeuticdrugsonhumanmonocyte-deriveddendriticcelldifferentiationandantigenpresentation.ClinExpImmunol.2013Jun;172(3):490-9.PMID:23600838.

PanP,LiY,YuH,etal.MolecularprincipleoftopotecanresistancebytopoisomeraseImutationsthroughmolecularmodelingapproaches.JChemInfModel.2013Apr22;53(4):997-1006.PMID:23521602.

ChenAY,ChenPM,ChenYJ.DNAtopoisomeraseIdrugsandradiotherapyforlungcancer.JThoracDis.2012Aug;4(4):390-7.PMID:22934142.

ChintalaS,TóthK,CaoS,etal.Se-methylselenocysteinesensitizeshypoxictumorcellstoirinotecanbytargetinghypoxia-inducIBLefactor1alpha.CancerChemotherPharmacol.2010Oct;66(5):899-911.PMID:20066420.

DoddsHM,RivoryLP.Themechanismfortheinhibitionofacetylcholinesterasesbyirinotecan(CPT-11).MolPharmacol.1999Dec;56(6):1346-53.PMID:10570064.

品牌介绍
LKT Labs LKT Labs 是一家专注于防癌抗癌特殊化学品研究和开发的公司。主要提供:癌症药物、药物发现试剂盒、天然产物、广泛的生命科学研究试剂、定制合成。美国LKT Labs 是1988年在美国成立的,为全球提供先端的药物研发试剂、试剂盒、委托合成,并为药物生产企业提供原料,最近几年在农药、水产养殖业有很大程度的开发。在LKT Labs 可以找到在其他地方找不到的产品。 试剂